3rd ADC Payload Summit 2026

 

The 3rd ADC Payload Summit is the only industry-led meeting dedicated exclusively to advancing ADC payload innovation.

Taking place November 4-6, 2026, in Boston, the summit will bring together 70+ experts across payload discovery, medicinal chemistry, biology, translational science, toxicology, and ADC development to address the key challenges shaping the future of antibody-drug conjugates.

Attendees will gain insights into novel payload mechanisms, dual-payload ADC strategies, resistance biology, therapeutic index optimization, and clinical translation from leading organizations including AstraZeneca, AbbVie, GSK, Takeda, GeneQuantum Healthcare, Hexagon Bio, and Callio Therapeutics, while building valuable connections with peers driving the next generation of ADC innovation.

 

More Info

---

---